|[August 19, 2014]
Research and Markets: Global Cancer Generics (Oral & Injectables) Market Outlook to 2018
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/9gzt3d/global_cancer)
has announced the addition of the "Global
Cancer Generics Market Outlook 2018" report to their offering.
With the advent of novel and innovative technologies, industries like
healthcare and pharmaceutical are scaling newer heights. One such market
is the oncology market. With global cancer incidences rising to almost
14.1 Million in 2012 and several blockbuster cancer drugs losing their
patent protection, the market for cancer generics is bound to experience
According to this latest research report Global Cancer Generics Market
Outlook 2018, the global oncology market touched a mark of US$ 91
Billion in 2013 and is poised to grow at a CAGR of approximately 6% over
the next 5 year period. On the other hand, the market for cancer
generics is expected to grow at 12%, reaching US$ 21 Billion by 2018.
Patent expiry, low cost, and better life expectancy would be the major
boosting factors for the cancer generics industry.
The report essentially elicits the cancer industry under 2 heads viz.
global oncology market and global caner generics market. Hereunder,
cancer incidences are discussed providin an insight about the
geographical share and country wise incidence rate. Furthermore, the
generic cancer drugs are scrutinized according to their dosage form. In
addition to that, the cancer generics industry with respect to major
indications is also discussed in depth, with emphasis on current and
future incidences, regional analysis and patent expiration status of key
cancer drugs. Analysis of key industry trends and drivers crucial to the
market is also added.
Apart from the above mentioned study parameters the dossier also
contains an analysis of the top notch global cancer generics
manufacturers. On a holistic basis, the report is primarily inclined
towards an in-depth study of the global cancer generics market,
asserting the fact that Cancer Generics is going to be the focus area
for several industry players, thereby labelling Cancer Generics as a
field with substantial growth potential over the next few years.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Global Cancer Drugs Market Outlook 2018
4. Global Cancer Generics Market Analysis 2018
5. Cancer Generic Drugs Industry
Oral Generic Drugs
Camptosar (Irinotecan Hydrochloride)
Gemzar (Gemcitabine Hydrochloride)
Navelbine (Vinorelbine Tartrate)
6. Cancer Generics Market: Major Indications
7. Market Dynamics
Indian Generic Cancer Drug Introduced in the US Market
Launch of Generic Drugs for Oncology
Increasing Cancer Burden Paving Way for Generics
Patent Expiry of Blockbuster Oncology Drugs
8. Key Players
Fresenius Kabi AG
Teva Pharmaceutical Industries Ltd.
For more information visit http://www.researchandmarkets.com/research/9gzt3d/global_cancer
[ Back To TMCnet.com's Homepage ]